论文部分内容阅读
随着国家对抗菌药物滥用的严厉整治,医药产业特别是抗菌药生产企业面临前所未有的严峻考验。抗菌药生产企业产量、销售和利润均出现大幅度下降,样本医院抗感染用药的占比出现负增长。本文就上述问题建议抗菌药生产企业在改善产品结构、开拓终端市场等方面尝试创新,以适应政策和市场的走势。
As the state severely punished the abuse of antimicrobial drugs, the pharmaceutical industry, especially the antibacterial drug manufacturers, is facing an unprecedented severe test. The output, sales and profit of antibacterial drug manufacturers dropped sharply, and the proportion of anti-infection drug in sample hospitals showed a negative growth. This article suggests that the antibacterial drug manufacturers should try to innovate in improving the product structure and opening up the terminal market to meet the policy and market trends.